1-3 of 3
Eva Demeckova
Close
Sort by
Journal Articles

Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry

Eva Demeckova, Martin Mistrik, MD, PhD, Ludmila Demitrovicova, Juraj Chudej, MD, Imrich Markuliak, Elena Tothova, Jan Muzik, MSci, PhD, Ladislav Dusek
Journal: Blood
Blood (2011) 118 (21): 4439.
https://doi.org/10.1182/blood.V118.21.4439.4439
Published: 2011
Journal Articles

Is Standard Treatment (DA 3+7) Is Still Recommended As Front Line Therapy for Adult Patients with De Novo AML? the Role of Etoposide

Firas Al Sabty, MD, PhD, Eva Demeckova, Ladislav Sopko, Eva Weismanova, Martin Mistrik, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4272.
https://doi.org/10.1182/blood.V118.21.4272.4272
Published: 2011
Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Hana Klamova, Daniela Zackova, Edgar Faber, MD, PhD, Katerina Steinerova, Michal Karas, Eva Demeckova, Jaroslava Voglova, MD, Ludmila Demitrovicova, Elena Tothova, Juraj Chudej, MD, Imrich Markuljak, Tomas Kozak, Eduard Cmunt, M.D., Ph.D., Marie Jarosova, Katerina Machova-Polakova, Kyra Michalova, PhD, DSc, Ladislav Dusek, Jan Muzik, Martin Mistrik, Jiri Mayer, MD, PhD, Marek Trneny, MD, PhD, Karel Indrak, MD., PhD.
Journal: Blood
Blood (2010) 116 (21): 1239.
https://doi.org/10.1182/blood.V116.21.1239.1239
Published: 2010